1 / 69

Tuberculosis and other Mycobacterial Infections

Tuberculosis and other Mycobacterial Infections. Charles S. Bryan, M.D. November 27, 2007. Tuberculosis: current problems. About 3.8 million cases per year; 90% (and 98% of the 3 million deaths) are in developing countries Multidrug resistance (“MDR-TB”)

arleen
Download Presentation

Tuberculosis and other Mycobacterial Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Tuberculosis and other Mycobacterial Infections Charles S. Bryan, M.D. November 27, 2007

  2. Tuberculosis: current problems • About 3.8 million cases per year; 90% (and 98% of the 3 million deaths) are in developing countries • Multidrug resistance (“MDR-TB”) • AIDS: atypical presentations and distribution • Nosocomial spread • Foreign-born

  3. Number of reported cases of TB by year of diagnosis, USA, 1982-2003

  4. Number and percentage of cases of TB among foreign-born persons, by year of diagnosis, USA, 1986-2003

  5. TB incidence among five racial/ethnic populations, USA, 2003

  6. Mycobacterium tuberculosis • An obligate aerobe: prefers P02 of 130 torr • Replicates every 20 hours • Natural resistance to one drug is one in every 105 to 107 cells • Natural resistance to two or more drugs is 1 in every 109 to 1012 cells

  7. Tuberculosis: the basics • The Mycobacterium tuberculosis complex: M. tuberculosis, M. bovis, M. africanum • Transmitted primarily by airborne droplet nuclei • Persons with positive AFB sputum smears are especially effective transmitters • Between 5% and 15% of infected persons will develop active disease (involving any organ) within two years

  8. Tuberculosis: the basics (2) • Populations at increased risk of infection: medically-underserved, low-income groups; immigrants; residents of long-term care or correctional facilities • Infected persons with increased risk of active disease: close contacts of cases; children < 5 years old; persons with chronic diseases (renal failure; silicosis; diabetes); immunosuppressed; HIV-positive persons

  9. Immunology of tuberculosis • Tubercle bacillus + macrophages --> processed antigen • Antigen recognition by lymphocytes --> activated lymphocytes --> lymphokines • Lymphokines--> attraction, stimulation, and retention of macrophages at antigen site • Activated macrophages--> lytic enzymes with mycobactericidal but also tissue-necrosing capacity

  10. Immunology of tuberculosis (2) • Interferon-gamma probably stimulates macrophages to produce interferon-alfa and 1,25-dihydroxyvitamin D, both of which are mycobacterial inhibitors • Cytokines secreted by alveolar macrophages: interleukin 1 (fever); interleukin 6 (hyperglobulinemia), and tumor necrosis factor alpha (killing of organisms, granuloma formation, fever and weight loss)

  11. Pathogenesis of tuberculosis

  12. Primary tuberculous infection • Inhalation leads to infection at periphery of middle lung zone • Pneumonia 2 to 6 weeks after infection followed by lymphohematogenous dissemination • Cell-mediated immunity (manifested by positive PPD) usually contains the infection • Some organisms remain viable

  13. Reactivation of tuberculosis • Occurs most often in persons > 50 years of age; more common in men • Higher risk in elderly persons and in those with malnutrition, diabetes mellitus, post-gastrectomy, immunocompromise, alcoholism, HIV infection, or corticosteroid therapy

  14. Residua of primary infection • Ghon complex (after Anton Ghon, German bacteriologist): calcified peripheral focus of tuberculous infection with calcified regional (hilar) lymph node (also called Ranke complex) • Simon focus (after Georg Simon, German pediatrician): focus at apex of lung, containing viable organisms and manifested on x-ray as “fibrous cap”

  15. Axioms on Simon foci • “If humans did not have apices to their lungs, the tubercle bacillus would not have survived as a human pathogen.” • “Once a Simon focus has formed, one will eventually die of tuberculosis if something else doesn’t cause death first.”

  16. Progression to active tuberculosis • One year after infection: approximately 5% • Thereafter: approximately 5% (lifetime) • It now seems that many people eventually outlive their tubercle bacilli and are consequently vulnerable to reinfection (Stead, studies in Arkansas, early 1980s) • Tuberculin-positive persons with HIV infection: risk is 7% to 10% per year

  17. Insights from genotyping of M. tuberculosis isolates (N Engl J Med 2003; 349: 1149-1155) • Previously, it was thought that 90% of TB cases in industrialized nations resulted from reactivation of infection acquired in remote past. • It now seems that recent transmission causes 40% to 50% of TB cases in urban areas.

  18. The cavity (1) • Formation of the cavity is the pivotal event in the evolution of pulmonary tuberculosis. • Mortality of cavitary pulmonary tuberculosis without treatment approaches 90%. • All therapies prior to 1948 were aimed at closing cavities.

  19. The cavity (2) • Even healed, cavities are unstable. • The walls of cavities contain extensive sheets of bacilli (up to 1011 bacilli/gram). • The cavity is thinnest at the point of penetration of bronchi. • Open cavities may persist for years, constantly draining bacilli into the rest of the bronchial tree.

  20. Complications of pulmonary tuberculosis • Cough, fever, night sweats, weight loss, anemia • Massive hemoptysis (erosion of a vessel in the wall of a cavity; a dilated vessel in a cavity (Rasmussen’s aneurysm; or an aspergilloma) • Progressive pulmonary disease, rarely ARDS • Hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone (SIADH)

  21. Major syndromes of extrapulmonary tuberculosis • Disseminated (miliary) tuberculosis • “Serosal” tuberculosis (anatomic spaces or cavities): pleurisy, pericarditis, meningitis, peritonitis, arthritis • Tuberculosis of solid organs: renal (genitourinary), osteomyelitis, adrenal glands (Addison’s disease), lymph nodes

  22. Miliary tuberculosis: diagnostic aids • Repeat physical examination: choroidal tubercles, palpable lymph nodes • Repeat CXR and tuberculin test • Cultures: sputum (up to 63% positive), urine, bone marrow, CSF, gastric aspirate, pleural fluid • Biopsy: palpable nodes, marrow, liver • Therapeutic trial

  23. “Cryptic miliary tuberculosis” • An occult illness with gradual decline in general health • Often no significant fever • Non-reactive tuberculin skin test • Normal chest x-ray

  24. Frequency order of extrapulmonary sites 1. Lymph node 2. Pleura 3. Genitourinary tract 4. Bone and joints 5. Meninges 6. Peritoneum

  25. Tuberculous pleurisy • Subpleural focus ruptures into the pleural space • Usually younger adults, 3 to 7 months after primary tuberculous infection • Abrupt or insidious onset. DDx: pneumonia, pulmonary infarct, tumor, others • Natural history untreated: 65% of 141 patients developed active tbc (Roper & Waring)

  26. Tuberculous meningitis • Rupture of subependymal tubercle into subarachnoid space (“Rich focus”; Rich and McCormack, 1933) • The intrathecal tuberculin reaction (instillation of PPD material into CSF of PPD-positive volunteers) • Usually occurs within first 6 months of infection; now seen in older adults

  27. Tuberculous pericarditis • Rupture of a tuberculous mediastinal lymph node into the pericardial sac • Mortality 80% to 90% without treatment. Major problems even with appropriate Rx • Diagnosis is difficult to make short of total pericardiectomy • Constrictive pericarditis • Can extend into myocardium --> fiber atrophy

  28. Tuberculous peritonitis • Onset is usually insidious. Mortality 45% to 55% untreated but as low as 0% to 4% with treatment • Polar types: plastic or adhesive type (“doughy abdomen”) and exudative or serous peritonitis with ascites • Presentations: debilitating FUO; chronic abdominal pain; ascites of unknown origin

  29. Tuberculous arthritis • Tuberculous focus in bone ruptures into joint space; trauma predisposes • Adults: spine 50%, hips 15% • Children: Knees 15% • Insidious joint pain and swelling, most often involving large weight-bearing joints • Absence of proteolytic enzymes explains preservation of joint space

  30. Genitourinary tuberculosis • Tubercle of the glomerulus ruptures into the calyceal system • May progress to involve the entire kidney (“autonephrectomy”) and/or may spread throughout the GU tract (prostatitis, epididymitis, salpingitis) • Insidious onset

  31. Tuberculous osteomyelitis • Subchondral osteoporosis with surrounding ring of sclerosis • Spine: anterior involvement of vertebral bodies with disk collapse (Pott’s disease) • Suspect: Monoarticular arthritis of insidious onset; paraspinous mass; back pain

  32. Tuberculosis of the adrenal glands (Addison’s disease) • Tuberculosis formerly the major cause of the disease as described by Thomas Addison (now rare; most common cause is idiopathic [autoimmune]) • Wasting, hyperpigmentation, low blood pressure, hyponatremia, hyperkalemia

  33. Tuberculosis in HIV-positive patients • Present in 5% to 35% of patients diagnosed with AIDS • Precedes diagnosis of AIDS in 67% of patients • Although most of these cases result from reactivation, CXR often resembles progressive primary tuberculosis • Multiple drug resistance a major problem

  34. AFB smears • Three morning specimens • Fluorescent methods are more sensitive than traditional Kinyoun or Ziehl-Neelsen method • Predictive value of a positive test decreases strikingly as prevalence of the disease decreases (Bayes’ s theorem)

More Related